Castration-resistant Prostate Cancer
📧 Sign up to get email alerts when something new happens for Castration-resistant Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-23Clinical Trial Update: Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate Cancer [Phase 1]
This document provides an update on a completed Phase 1 study of abiraterone acetate in castration-resistant prostate cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer [Phase 2]
Phase 2 trial of orteronel for metastatic castration-resistant prostate cancer was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer [Phase 1]
Phase 1 trial evaluating the combination of Sipuleucel-T and Ipilimumab for advanced or castration-resistant prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer [Phase 1]
A Phase I trial evaluating cabazitaxel, mitoxantrone, and prednisone in metastatic castration-resistant prostate cancer has completed enroll…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis [Phase 2]
Phase 2 trial update investigating NaF PET/CT imaging to assess treatment response to TAK-700 in castration-resistant prostate cancer with b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer [Phase 1, Phase 2]
AEZS-108, a doxorubicin-GnRH agonist conjugate, completed Phase 1/2 testing in metastatic hormone-resistant prostate cancer. The trial was c…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of ONC1-0013B in Patients With Progressive Metastatic Castration-resistant Prostate Cancer [Phase 1]
Phase 1 clinical trial results for ONC1-0013B in progressive metastatic castration-resistant prostate cancer report safety, tolerability, an…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating abiraterone acetate plus prednisone with or without dasatinib for metastatic castration-resistant prosta…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC) [Phase 2]
Phase IIa randomized study evaluating radium-223 dichloride with abiraterone acetate or enzalutamide in metastatic castration-resistant pros…
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates [Phase 1]
Phase 1 trial evaluated pharmacokinetic interactions between MDV3100 (enzalutamide) and a substrate cocktail. The study, conducted in castra…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer [Phase 2]
Phase 2 trial results for combining abiraterone acetate with dutasteride in metastatic castration-resistant prostate cancer have been posted…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer [Phase 2]
Phase 2 trial comparing concurrent versus sequential sipuleucel-T and abiraterone in metastatic castration-resistant prostate cancer has com…
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer [Phase 4]
Phase 4 study evaluating enzalutamide after abiraterone treatment in metastatic castration-resistant prostate cancer has completed and poste…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer [Phase 1]
A Phase 1 trial assessing imaging-based response to Radium-223 dichloride in metastatic, hormone-resistant prostate cancer; the study has be…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer [Phase 2]
Phase II study evaluating DCVAC/PCa added to standard chemotherapy for metastatic castration-resistant prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer [Phase 3]
Phase 3 trial evaluating orteronel plus prednisone in chemotherapy-naive metastatic castration-resistant prostate cancer has completed and p…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Expression of Molecular Markers in Circulating Tumor Cells of Metastatic Castration-Resistant Prostate Cancer
A clinical trial update examining expression of molecular markers in circulating tumor cells from patients with metastatic castration-resist…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer [Phase 1]
Phase 1 clinical trial update evaluating whether dietary fat levels affect uptake of abiraterone acetate in metastatic hormone-resistant pro…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: BKM120 in Metastatic Castration-resistant Prostate Cancer [Phase 2]
A Phase 2 trial of buparlisib (BKM120) for metastatic castration-resistant prostate cancer was terminated, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer [Phase 2]
A Phase 2 trial evaluating navitoclax with abiraterone acetate, with or without hydroxychloroquine, in progressive metastatic castration-res…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial update showing safety and pharmacokinetics data for ODM-201 (darolutamide) in castration-resistant prostate cancer;…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Metformin in Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 trial of metformin in castration-resistant prostate cancer was terminated, with results posted in 2017 by Massachusetts General Hosp…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC) [Phase 2]
Phase 2 trial of a PSMA-targeted antibody-drug conjugate in metastatic castration-resistant prostate cancer has completed enrollment and pos…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: An Open-label Extension Study of PSMA ADC 2301 in mCRPC [Phase 2]
An open-label extension study of PSMA ADC 2301 in metastatic castration-resistant prostate cancer (Phase 2) has completed, with results post…
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate Cancer [Phase 1, Phase 2]
Clinical trial update indicates termination of a Phase 1/2 study evaluating an RNActive-derived vaccine for metastatic castration-resistant …